Evidence map›Paper›PMID 31054214›Full record

ArticleInternational journal of cancer2020

Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya.

Sally Peprah, Martin D Ogwang, Patrick Kerchan, Steven J Reynolds, Constance N Tenge, Pamela A Were, Robert T Kuremu, Walter N Wekesa, Peter O Sumba, Nestory Masalu and 16 more

Open access · greenAbstract read
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Malaria Infection and Risk for Endemic Burkitt Lymphoma: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Plasma metabolites in childhood Burkitt lymphoma cases and cancer-free controls in Uganda.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Article
  14. Mechanism of Immune Evasion in Mosquito-Borne Diseases.Pathogens (Basel, Switzerland) · 2023
    Review
  15. Burkitt lymphoma risk shows geographic and temporal associations withProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 9 institutions in 5 countries.

Sally PeprahDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Martin D OgwangEMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
Patrick KerchanAfrican Field Epidemiology Network, Kampala, Uganda.
Steven J ReynoldsDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Constance N TengeEMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
Pamela A WereEMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Robert T KuremuEMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
Walter N WekesaEMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.
Peter O SumbaKenya Medical Research Institute, Kisumu, Kenya.
Nestory MasaluEMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
Esther KawiraEMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
Josiah MagattiEMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
Tobias KinyeraEMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
Isaac OtimEMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
Ismail D LegasonAfrican Field Epidemiology Network, Kampala, Uganda.
Hadijah NabalendeEMBLEM Study, St. Mary's Hospital Lacor, Gulu, Uganda.
Herry DhudhaEMBLEM Study, Shirati Health and Educational Foundation, Shirati, Tanzania.
Hillary AllyEMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.
Isaiah O GengaEMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Mediatrix MumiaEMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.
Leona W AyersDepartment of Pathology, The Ohio State University, Columbus, OH.
Ruth M PfeifferDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Robert J BiggarDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Kishor BhatiaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
James J GoedertDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Sam M MbulaiteyeDivision of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-8273-9831
National Institutes of Health · USSt. Mary's Hospital Lacor · UGAMPATH · KEMental Health Foundation · GBMoi University · KEBugando Medical Centre · TZKuluva Hospital · UGKenya Medical Research Institute · KEThe Ohio State University · US

Funding

Infections, immunity, and inflammation in cancerZIACP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2009 to 2025
$24.0M
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
Infections, immunity, and inflammation in cancerZ01CP010150 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ENGELS, ERIC A · 2000 to 2008
$3.0M
Intramural NIH HHS Z01 CP010150NCI NIH HHS HHSN261201100007INCI NIH HHS HHSN261201100063CNHLBI NIH HHS HHSN261201100007C
6 · The paper itself

Abstract

Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in sub-Saharan African countries, however, few epidemiologic studies have been undertaken and none attempted enrolling cases from multiple countries. We therefore conducted a population-based case-control study of eBL in children aged 0-15 years old in six regions in Northern Uganda, Northern Tanzania and Western Kenya, enrolling 862 suspected cases and 2,934 population controls (response rates 98.5-100%), and processing ~40,000 vials of samples using standardized protocols. Risk factor questionnaires were administered, and malaria period prevalence was measured using rapid diagnostic tests (RDTs). A total of 80.9% of the recruited cases were diagnosed as eBL; 61.4% confirmed by histology. Associations with eBL risk were computed using logistic regression models adjusted for relevant confounders. Associations common in at least two countries were emphasized. eBL risk was decreased with higher maternal income and paternal education and elevated with history of inpatient malaria treatment >12 months before enrollment. Reporting malaria-attributed fever up to 6 months before enrollment and malaria-RDT positivity at enrollment were associated with decreased eBL risk. Conversely, reporting exposure to mass malaria suppression programs (e.g., indoor residual insecticide) was associated with elevated risk. HIV seropositivity was associated with elevated eBL risk, but the relative impact was small. The study shows that it is feasible to conduct networked, multisite population-based studies of eBL in Africa. eBL was inversely associated with socioeconomic status, positively associated with inpatient malaria treatment 12 months ago and with living in areas targeted for malaria suppression, which support a role of malaria in eBL.

Indexed as

Socioeconomic FactorsAdolescentBurkitt LymphomaCase-Control StudiesChildChild, PreschoolEndemic DiseasesFemaleHIV SeropositivityHumansInfantInfant, NewbornKenyaMalariaMalePrevalenceBurkitt lymphomaepidemiologyEpstein-Barr virusHIV/AIDSnon-Hodgkin lymphomaPlasmodium falciparum malaria

Identifiers

PMID31054214
PMCPMC6829037
OpenAlexW2944256909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.